Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery.
Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery.
复制标题
DOI:
10.1245/s10434-020-09288-7
复制
发表时间:
2021-07
影响因子:
3.7
通讯作者:
Leff DR
中科院分区:
文献类型:
--
作者:
Kedrzycki MS;Leiloglou M;Ashrafian H;Jiwa N;Thiruchelvam PTR;Elson DS;Leff DR
Conventional methods for axillary sentinel lymph node biopsy (SLNB) are fraught with complications such as allergic reactions, skin tattooing, radiation, and limitations on infrastructure. A novel technique has been developed for lymphatic mapping utilizing fluorescence imaging. This meta-analysis aims to compare the gold standard blue dye and radioisotope (BD-RI) technique with fluorescence-guided SLNB using indocyanine green (ICG). This study was registered with PROSPERO (CRD42019129224). The MEDLINE, EMBASE, Scopus, and Web of Science databases were searched using the Medical Subject Heading (MESH) terms ‘Surgery’ AND ‘Lymph node’ AND ‘Near infrared fluorescence’ AND ‘Indocyanine green’. Studies containing raw data on the sentinel node identification rate in breast cancer surgery were included. A heterogeneity test (using Cochran’s Q) determined the use of fixed- or random-effects models for pooled odds ratios (OR). Overall, 1748 studies were screened, of which 10 met the inclusion criteria for meta-analysis. ICG was equivalent to radioisotope (RI) at sentinel node identification (OR 2.58, 95% confidence interval [CI] 0.35–19.08, p < 0.05) but superior to blue dye (BD) (OR 9.07, 95% CI 6.73–12.23, p < 0.05). Furthermore, ICG was superior to the gold standard BD-RI technique (OR 4.22, 95% CI 2.17–8.20, p < 0.001). Fluorescence imaging for axillary sentinel node identification with ICG is equivalent to the single technique using RI, and superior to the dual technique (RI-BD) and single technique with BD. Hospitals using RI and/or BD could consider changing their practice to ICG given the comparable efficacy and improved safety profile, as well as the lesser burden on hospital infrastructure. The online version of this article (10.1245/s10434-020-09288-7) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
3.7
作者:
Chi C;Ye J;Ding H;He D;Huang W;Zhang GJ;Tian J
通讯作者:
Tian J
影响因子:
3.9
作者:
Demarchi, Marco Stefano;Karenovics, Wolfram;Triponez, Frederic
通讯作者:
Triponez, Frederic
DOI:
10.1016/s1470-2045(14)70460-7
发表时间:
2014-11
期刊:
The Lancet. Oncology
影响因子:
--
作者:
Donker M;van Tienhoven G;Straver ME;Meijnen P;van de Velde CJ;Mansel RE;Cataliotti L;Westenberg AH;Klinkenbijl JH;Orzalesi L;Bouma WH;van der Mijle HC;Nieuwenhuijzen GA;Veltkamp SC;Slaets L;Duez NJ;de Graaf PW;van Dalen T;Marinelli A;Rijna H;Snoj M;Bundred NJ;Merkus JW;Belkacemi Y;Petignat P;Schinagl DA;Coens C;Messina CG;Bogaerts J;Rutgers EJ
通讯作者:
Rutgers EJ
影响因子:
2.7
作者:
Grischke, E. -M.;Roehm, C.;Wallwiener, D.
通讯作者:
Wallwiener, D.
影响因子:
45.3
作者:
Giuliano, AE;Haigh, PI;Turner, RR
通讯作者:
Turner, RR